Preview: Arcus Biosciences's Earnings
Portfolio Pulse from Benzinga Insights
Arcus Biosciences (NYSE:RCUS) is set to release its latest quarterly earnings report on Monday, 2023-08-07. Analysts estimate an earnings per share (EPS) of $-1.00. The company's past performance shows a trend of beating EPS estimates but this has often been followed by a drop in share price. The stock is currently trading at $19.03, down 29.94% over the last 52-week period.
August 04, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Arcus Biosciences is expected to report an EPS of $-1.00 in its upcoming earnings report. The company's history of beating EPS estimates has often led to a drop in share price. The stock is currently down 29.94% over the last 52-week period.
Arcus Biosciences has a history of beating EPS estimates, which is generally a positive signal. However, this has often been followed by a drop in share price, indicating that the market may have different expectations. The stock's negative performance over the last 52 weeks also suggests a bearish sentiment among investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100